259 related articles for article (PubMed ID: 27924722)
21. High urinary sulfate concentration is associated with reduced risk of renal disease progression in type 2 diabetes.
van den Born JC; Frenay AR; Bakker SJ; Pasch A; Hillebrands JL; Lambers Heerspink HJ; van Goor H
Nitric Oxide; 2016 May; 55-56():18-24. PubMed ID: 26952289
[TBL] [Abstract][Full Text] [Related]
22. Detection of an earlier tubulopathy in diabetic nephropathy among children with normoalbuminuria.
Hafez MH; El-Mougy FA; Makar SH; Abd El Shaheed S
Iran J Kidney Dis; 2015 Mar; 9(2):126-31. PubMed ID: 25851291
[TBL] [Abstract][Full Text] [Related]
23. Beta2-microglobulin and cystatin C in type 2 diabetes: assessment of diabetic nephropathy.
Aksun SA; Ozmen D; Ozmen B; Parildar Z; Mutaf I; Turgan N; Habif S; Kumanlioğluc K; Bayindir O
Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):195-200. PubMed ID: 15127324
[TBL] [Abstract][Full Text] [Related]
24. NLRP3 expression and urinary HSP72 in relation to biomarkers of inflammation and oxidative stress in diabetic nephropathy patients.
El-Horany HE; Abd-Ellatif RN; Watany M; Hafez YM; Okda HI
IUBMB Life; 2017 Aug; 69(8):623-630. PubMed ID: 28631886
[TBL] [Abstract][Full Text] [Related]
25. Albuminuria and diabetic nephropathy.
Chang SS
Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():974-9. PubMed ID: 18806713
[TBL] [Abstract][Full Text] [Related]
26. Urinary podocyte-associated mRNA profile in various stages of diabetic nephropathy.
Zheng M; Lv LL; Ni J; Ni HF; Li Q; Ma KL; Liu BC
PLoS One; 2011; 6(5):e20431. PubMed ID: 21655212
[TBL] [Abstract][Full Text] [Related]
27. Clinical verification of a novel urinary microRNA panal: 133b, -342 and -30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis.
Eissa S; Matboli M; Bekhet MM
Biomed Pharmacother; 2016 Oct; 83():92-99. PubMed ID: 27470555
[TBL] [Abstract][Full Text] [Related]
28. Urinary podocalyxin levels were associated with urinary albumin levels among patients with diabetes.
Shoji M; Kobayashi K; Takemoto M; Sato Y; Yokote K
Biomarkers; 2016; 21(2):164-7. PubMed ID: 26635084
[TBL] [Abstract][Full Text] [Related]
29. Diabetic nephropathy induces changes in the proteome of human urinary exosomes as revealed by label-free comparative analysis.
Zubiri I; Posada-Ayala M; Sanz-Maroto A; Calvo E; Martin-Lorenzo M; Gonzalez-Calero L; de la Cuesta F; Lopez JA; Fernandez-Fernandez B; Ortiz A; Vivanco F; Alvarez-Llamas G
J Proteomics; 2014 Jan; 96():92-102. PubMed ID: 24211404
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of statins in patients with diabetic nephropathy: a meta-analysis of randomized controlled trials.
Shen X; Zhang Z; Zhang X; Zhao J; Zhou X; Xu Q; Shang H; Dong J; Liao L
Lipids Health Dis; 2016 Oct; 15(1):179. PubMed ID: 27733168
[TBL] [Abstract][Full Text] [Related]
31. von Willebrand factor and development of diabetic nephropathy in IDDM.
Stehouwer CD; Stroes ES; Hackeng WH; Mulder PG; Den Ottolander GJ
Diabetes; 1991 Aug; 40(8):971-6. PubMed ID: 1907250
[TBL] [Abstract][Full Text] [Related]
32. Urinary MCP-1 and RBP: independent predictors of renal outcome in macroalbuminuric diabetic nephropathy.
Titan SM; Vieira JM; Dominguez WV; Moreira SR; Pereira AB; Barros RT; Zatz R
J Diabetes Complications; 2012; 26(6):546-53. PubMed ID: 22981148
[TBL] [Abstract][Full Text] [Related]
33. Urinary biomarkers for early diabetic nephropathy: beyond albuminuria.
Lee SY; Choi ME
Pediatr Nephrol; 2015 Jul; 30(7):1063-75. PubMed ID: 25060761
[TBL] [Abstract][Full Text] [Related]
34. Validity of biomarkers predicting onset or progression of nephropathy in patients with Type 2 diabetes: a systematic review.
Hellemons ME; Kerschbaum J; Bakker SJ; Neuwirt H; Mayer B; Mayer G; de Zeeuw D; Lambers Heerspink HJ; Rudnicki M
Diabet Med; 2012 May; 29(5):567-77. PubMed ID: 21913962
[TBL] [Abstract][Full Text] [Related]
35. Factors Associated with Microalbuminuria Remission in Patients with Type 2 Diabetes: Importance of Early Intervention for Microalbuminuric Patients (TSUGARU STUDY).
Nakamura N; Narita I; Fujita T; Murakami R; Shimada M; Nakamura M; Osawa H; Yamabe H; Okumura K;
In Vivo; 2017; 31(3):285-290. PubMed ID: 28438853
[TBL] [Abstract][Full Text] [Related]
36. Analysis of circulating lncRNA expression profiles in patients with diabetes mellitus and diabetic nephropathy: Differential expression profile of circulating lncRNA
.
Yang Y; Lv X; Fan Q; Wang X; Xu L; Lu X; Chen T
Clin Nephrol; 2019 Jul; 92(1):25-35. PubMed ID: 31079598
[TBL] [Abstract][Full Text] [Related]
37. [Early detection by urinary proteome analysis : A new concept in patient management of diabetic nephropathy].
Beige J; Drube J; von der Leyen H; Pape L; Rupprecht H
Internist (Berl); 2020 Oct; 61(10):1094-1105. PubMed ID: 32897404
[TBL] [Abstract][Full Text] [Related]
38. Effects of pregnancy on the onset and progression of diabetic nephropathy and of diabetic nephropathy on pregnancy outcomes.
Young EC; Pires ML; Marques LP; de Oliveira JE; Zajdenverg L
Diabetes Metab Syndr; 2011; 5(3):137-42. PubMed ID: 22813566
[TBL] [Abstract][Full Text] [Related]
39. Effect of tranilast in early-stage diabetic nephropathy.
Soma J; Sato K; Saito H; Tsuchiya Y
Nephrol Dial Transplant; 2006 Oct; 21(10):2795-9. PubMed ID: 16820373
[TBL] [Abstract][Full Text] [Related]
40. Discovery and validation of serum creatinine variability as novel biomarker for predicting onset of albuminuria in Type 2 diabetes mellitus.
Low S; Zhang X; Ang K; Yeo SJD; Lim GJ; Yeoh LY; Liu YL; Subramaniam T; Sum CF; Lim SC
Diabetes Res Clin Pract; 2018 Apr; 138():8-15. PubMed ID: 29355653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
